ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO0153

Adipose-Derived Mesenchymal Stem Cells Extracellular Vesicles Attenuate AKI by TXNIP-IKKα/NFκB

Session Information

  • AKI: Mechanisms - 1
    November 06, 2025 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Acute Kidney Injury

  • 103 AKI: Mechanisms

Author

  • Deng, Weijuan, Department of Nephrology, Sir Run Run hospital, Nanjing Medical University, Nanjing, China
Background

Extracellular vesicles produced by mesenchymal stem cells (MSC-EVs) have received widespread attention as a cell-free treatment option for acute kidney injury (AKI). The underlying processes and capabilities of MSC-EVs in mitigating kidney injury remain largely unclear.

Methods

Establishment of AKI mouse models by cisplatin tail vein injection. AKI mice were further randomized to receive saline or adipose-derived mesenchymal stem cells-extracellular vesicles (AMSC-EVs) (50 μg) or AMSC-EVs (100 μg) into the tail vein. Ninety-six hours after injury, mice were sacrificed, and kidney tissue and blood samples were obtained for paraffin embedding and immunoblotting. To investigate the relationship between AMSC-EVs and kidney-resident macrophages, CX3CR1+ macrophage-specific conditional knockout mice (CX3CR1-Cre+/-; Rosa26-LSL-DTR+/-). In addition, a TXNIP (thioredoxin-interacting protein) overexpression assay was performed to analyze macrophage polarization and TXNIP-IKKα/NFκB signaling pathway expression.

Results

In mice, AMSC-EVs reduce tubular injury and ameliorate cisplatin-induced AKI in a dose-dependent manner. However, in the CX3CR1+ macrophage ablation group, AKI mice exhibited more severe tubular lesions compared to littermates, suggesting that the therapeutic effect of AMSC-EVs was diminished after CX3CR1+ ablation. At the same time, AMSC-EVs promote the polarization of kidney-resident macrophages to repairing M2 macrophages, leading to increased production of anti-inflammatory factors and subsequently altering the inflammatory microenvironment in renal tubular cells, thereby promoting the self-healing process in AKI mice. Mechanistically, AMSC-EVs inhibit the protein expression of TXNIP-IKKα/NFκB in kidney-resident macrophages. Finally, overexpression of TXNIP can attenuate the protective effect of AMSC-EVs on kidney-resident macrophages.

Conclusion

Our findings suggest that AMSC-EVs regulate the polarization of kidney-resident macrophages after cisplatin-induced AKI and promote renal self-recovery through the TXNIP-IKKα/NFκB signaling pathway.

Funding

  • Clinical Revenue Support

Digital Object Identifier (DOI)